Results 131 to 140 of about 16,072 (215)

A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis [PDF]

, 2015
George Johnson
core   +1 more source

Epidemiology and clinical spectrum of leishmaniasis due to Leishmania infantum in Tunisia: Current status, challenges, and perspectives. [PDF]

PLoS Negl Trop Dis
Chargui N, Amro A, Babba H, Haouas N.
europepmc   +1 more source

Leishmaniasis in Morocco: Epidemiology, Transmission Dynamics, and the Potential of Artificial Intelligence for Disease Management. [PDF]

J Parasitol Res
Harkat C, Sereno D, Aimrane A, Hidan MA, Yamani M, Kahime K.   +5 more
europepmc   +1 more source

Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by Leishmania amazonensis. [PDF]

Front Immunol, 2017
Pereira JC, Ramos TD, Silva JD, de Mello MF, Pratti JES, da Fonseca-Martins AM, Firmino-Cruz L, Kitoko JZ, Chaves SP, Gomes DCO, Diaz BL, Rocco PRM, de Matos Guedes HL.   +12 more
europepmc   +1 more source

Therapeutic challenges in relapsing cutaneous and visceral leishmaniasis caused by Leishmania (Mundinia) martiniquensis in patients with advanced HIV disease from Southern Thailand. [PDF]

Trop Med Health
Phadungsaksawasdi K, Songumpai N, Swasdivanich C, Rongngern P, Borriboon T, Savigamin C, Brownell N, Kraivichian K, Noppakun N, Siriyasatien P, Asawanonda P, Preativatanyou K.   +11 more
europepmc   +1 more source

Insights into drug resistance in <i>Leishmania</i>: Mechanisms, therapeutics, and clinical case studies. [PDF]

ADMET DMPK
Ghousepeer GD, Rani M, Kumar A, Singh SK, Priyadarshini A, Leal E, Singh S, Raj VS, Basu S, Pandey RP.   +9 more
europepmc   +1 more source

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by <i>Leishmania major</i>. [PDF]

Pharmaceutics
El-Dirany R, Ginatta P, Fernández-Rubio C, Burguete-Mikeo A, Larrea E, Martinez-de-Tejada G, Nguewa PA.   +6 more
europepmc   +1 more source

Ferroptosis and Nrf-2 signaling: a redox tug of war in leishmaniasis pathogenesis and host directed therapy. [PDF]

Redox Biol
Dar MJ, Huston RH, Purayil N, Cronin AI, Gondal SA, Nakhasi HL, Brito R, Gannavaram S, Satoskar AR.   +8 more
europepmc   +1 more source

<i>Acomys cahirinus seurati</i> as a Potential Reservoir Host of <i>Leishmania major</i>. [PDF]

Pathogens
Karlin S, Bečvářová B, Benallal KE, Bečvář T, Mezai G, Zaabar M, Mefissel M, Volf P, Sádlová J.   +8 more
europepmc   +1 more source

An Overview of the Factors Related to Leishmania Vaccine Development. [PDF]

Vaccines (Basel)
Passero LFD, Cavallone IN, Araújo Flores GV, de Lima Melchert SS, Laurenti MD.   +4 more
europepmc   +1 more source